Anti-human vista antibodies and use thereof Grant US-11649283-B2 United States of America 16 May 2023
Anti-human vista antibodies and use thereof Grant US-11603403-B2 United States of America 14 Mar 2023
Anti-human vista antibodies and use thereof Grant US-11603402-B2 United States of America 14 Mar 2023
Combination therapy with Axl inhibitor and immune checkpoint modulator or oncolytic virus Grant US-11534440-B2 United States of America 27 Dec 2022
Vista modulators for diagnosis and treatment of cancer Grant US-11529416-B2 United States of America 20 Dec 2022
Anti-human VISTA antibodies and use thereof Grant US-11525000-B2 United States of America 13 Dec 2022
Method of identifying a P-selectin glycoprotein ligand-1 (PSGL-1) antagonist Grant US-11306150-B2 United States of America 19 Apr 2022
Immune checkpoint molecular fitness profiling by mass spectrometry Grant US-11204355-B2 United States of America 21 Dec 2021
Vista modulators for diagnosis and treatment of cancer Grant US-11180557-B2 United States of America 23 Nov 2021
Identification of VSIG8 as the putative vista receptor and its use thereof to produce… Grant AU-2015357463-B2 Australia 07 Oct 2021
Use of vista agonists and antagonists to suppress or enhance humoral immunity Grant US-11123426-B2 United States of America 21 Sep 2021
Protein quantitation in multicellular tissue specimens Grant US-11047860-B2 United States of America 29 Jun 2021
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same Grant US-11014987-B2 United States of America 25 May 2021
Method of identifying anti-VISTA antibodies Grant US-10899836-B2 United States of America 26 Jan 2021
VISTA regulatory T cell mediator protein, VISTA binding agents and use thereof Grant US-10781254-B2 United States of America 22 Sep 2020
IDENTIFICATION OF VSIG8 AS THE PUTATIVE VISTA RECEPTOR AND ITS USE THEREOF TO PRODUCE… Application WO-2016090347-A1 World Intellectual Property Organisation (WIPO) 09 Jun 2016